Hyclone (GE)
HyClone (GE) has been working for nearly 50 years to provide high quality animal sera products for biological research and manufacturing, through innovations in collection and processing technologies. These serum products are perfectly partnered with their wide range of classical and serum free media; buffers and process liquids for research and bioproduction.
About GE Healthcare
GE Healthcare acquired Thermo Fisher’s HyClone™ cell culture media and sera, and gene modulation and magnetic beads businesses in 2014. GE Healthcare provides transformational medical technologies and services to meet the demand for increased access, enhanced quality, and more affordable healthcare around the world. GE (NYSE: GE) works on things that matter – great people and technologies taking on tough challenges. From medical imaging, software and IT, patient monitoring and diagnostics – to drug discovery, biopharmaceutical manufacturing technologies, and performance improvement solutions, GE Healthcare helps medical professionals deliver great healthcare to their patients. For more information about GE Healthcare, visit their website at www.gehealthcare.com
In Vitro Technologies can enable you to perform quality research by providing the following:
- FBS of consistent quality and performance
- Assistance with choosing a batch of serum and batch testing
- Options to save your serum costs
- Classical, Serum Free and Chemically defined media
- Buffers and Process liquids in various packaging sizes
- Optimising productivity of protein production
- Rapid turn around on custom media formulations
